DISCOVERY, DESIGN, AND ENGINEERING OF NANOBODY-BASED THERAPEUTICS FOR SARS-COV-2 .
Abstract not provided.
- Research Organization:
- Sandia National Laboratories (SNL-CA), Livermore, CA (United States); Sandia National Laboratories,, Emeryville, CA
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA)
- DOE Contract Number:
- NA0003525
- OSTI ID:
- 2003517
- Report Number(s):
- SAND2022-7648C; 707072
- Country of Publication:
- United States
- Language:
- English
Similar Records
DISCOVERY, DESIGN, AND ENGINEERING OF NANOBODY-BASED THERAPEUTICS FOR SARS-COV-2.
Development of Potent and Effective SARS-CoV-2 Neutralizing Nanobodies.
GENERATION OF HIGHLY EFFECTIVE SARS-COV-2 NEUTRALIZING HUMANIZED NANOBODIES.
Conference
·
Tue Nov 01 00:00:00 EDT 2022
·
OSTI ID:2006087
Development of Potent and Effective SARS-CoV-2 Neutralizing Nanobodies.
Conference
·
Sun Feb 28 23:00:00 EST 2021
·
OSTI ID:1861025
GENERATION OF HIGHLY EFFECTIVE SARS-COV-2 NEUTRALIZING HUMANIZED NANOBODIES.
Conference
·
Thu Dec 31 23:00:00 EST 2020
·
OSTI ID:1842252